Zhejiang Tailin Bioengineering Co Ltd Working Capital to Net Assets Ratio

Latest as of March 2026: 51.4%

Zhejiang Tailin Bioengineering Co Ltd working capital to net assets ratio. Zhejiang Tailin Bioengineering Co Ltd (300813) has a Working Capital to Net Assets ratio of 51.4% as of March 2026. Working capital of CN¥414.14 Million (current assets of CN¥552.05 Million minus current liabilities of CN¥137.91 Million) is measured against net assets of CN¥806.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Zhejiang Tailin Bioengineering Co Ltd (300813) tangible net worth to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

51.4%
Working Capital / Net Assets

Working Capital

CN¥414.14 Million
CNY

Current Assets

CN¥552.05 Million
CNY

Current Liabilities

CN¥137.91 Million
CNY

Working Capital to Net Assets Ratio of Zhejiang Tailin Bioengineering Co Ltd (2013–2025)

Working capital to net assets ratio of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025. This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 51.4%, reflecting working capital of CN¥414.14 Million against net assets of CN¥806.45 Million CNY. See Zhejiang Tailin Bioengineering Co Ltd (300813) defensive interval to measure how many days the company can operate on defensive assets alone.

Zhejiang Tailin Bioengineering Co Ltd Working Capital to Net Assets Ratio by Year (2013–2025)

Zhejiang Tailin Bioengineering Co Ltd working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Zhejiang Tailin Bioengineering Co Ltd's balance sheet.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 49.4% CN¥397.71 Million CN¥804.29 Million CN¥549.85 Million CN¥152.14 Million ▼ -11.1 pp
2024 60.6% CN¥496.98 Million CN¥820.73 Million CN¥632.76 Million CN¥135.79 Million ▼ -12.8 pp
2023 73.3% CN¥476.94 Million CN¥650.24 Million CN¥638.75 Million CN¥161.81 Million ▼ -24.6 pp
2022 98.0% CN¥634.21 Million CN¥647.45 Million CN¥763.54 Million CN¥129.33 Million ▲ +25.4 pp
2021 72.6% CN¥360.99 Million CN¥497.38 Million CN¥514.46 Million CN¥153.46 Million ▼ -1.8 pp
2020 74.3% CN¥330.22 Million CN¥444.24 Million CN¥426.28 Million CN¥96.06 Million ▲ +25.2 pp
2019 49.2% CN¥112.66 Million CN¥229.11 Million CN¥150.46 Million CN¥37.81 Million ▲ +7.4 pp
2018 41.8% CN¥81.30 Million CN¥194.70 Million CN¥141.72 Million CN¥60.42 Million ▼ -16.6 pp
2017 58.4% CN¥85.48 Million CN¥146.48 Million CN¥131.64 Million CN¥46.15 Million ▼ -7.0 pp
2016 65.4% CN¥76.05 Million CN¥116.31 Million CN¥115.27 Million CN¥39.22 Million ▼ -3.8 pp
2015 69.2% CN¥67.42 Million CN¥97.42 Million CN¥101.21 Million CN¥33.79 Million ▲ +25.7 pp
2014 43.5% CN¥23.94 Million CN¥55.04 Million CN¥47.30 Million CN¥23.35 Million ▼ -6.7 pp
2013 50.2% CN¥32.60 Million CN¥64.92 Million CN¥49.66 Million CN¥17.06 Million —
pp = percentage points